Liver diseases are any diseases that affect the functioning of the liver. ... semaglutide improved liver histology over 72 weeks. In another new study, ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...

The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...